» Articles » PMID: 34771524

Sarcopenia Predicts Cancer Mortality in Male but Not in Female Patients Undergoing Surgery for Cholangiocellular Carcinoma

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Nov 13
PMID 34771524
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Surgery represents the only curative treatment option for patients with cholangiocarcinoma. However, complete tumor resection requires extensive surgery in many patients, and it is still debated which patients represent the ideal candidates for such therapy in terms of overall survival. Sarcopenia has been associated with an adverse outcome for various malignancies, but its role in the context of patients undergoing tumor resection for cholangiocellular adenocarcinoma (CCA) is only poorly understood. Here, we evaluated the role of sarcopenia in the outcome of CCA patients undergoing radical tumor resection.

Methods: Pre-operative CT scans were used to assess the skeletal muscle index (L3SMI) as well as the psoas muscle index (L3PMI) in = 76 patients receiving curative intended surgery for CCA. L3SMI and L3PMI were correlated with clinical and laboratory markers.

Results: Patients with a skeletal muscle index or psoas muscle index above an established ideal cut-off (54.26 and 1.685 cm/m) showed a significantly better overall survival in Kaplan-Meier Curve analyses (L3SMI: 1814 days (95% CI: 520-3108) vs. 467 days (95% CI: 225-709) days; log rank X(1) = 7.18, = 0.007; L3PMI: 608 days (95% CI: 297-919) vs. 87 days (95% CI: 33-141), log rank X(1) = 18.71; < 0.001). Notably, these findings, especially for L3PMI, were confirmed in univariate (L3SMI: HR 0.962 (0.936-0.989); = 0.006; L3PMI: HR 0.529 (0.366-0.766); ≤ 0.001) and multivariate Cox regression analyses. Further analyses revealed that the prognostic value of both L3SMI and L3PMI was restricted to male patients, while in female patients survival was independent of the individual muscle mass.

Conclusion: Measurement of muscle mass from preoperative CT scans represents an easily obtainable tool to estimate patient prognosis following curative surgery. The prognostic value was restricted to male patients, while in female patients these parameters did not reflect the patient outcome.

Citing Articles

Joint association of systemic inflammatory response index and sarcopenia with mortality among individuals with self-reported cancer.

Huang Z, Peng W, Zhao M, Gao B, Qian J, Zhu S BMC Cancer. 2025; 25(1):267.

PMID: 39953396 PMC: 11829532. DOI: 10.1186/s12885-025-13653-8.


Body Composition in Cholangiocarcinoma Affects Immune Cell Populations in the Tumor and Normal Liver Parenchyma.

Wang G, Liu D, Al-Masri T, Otto C, Siveke J, Lang S J Clin Exp Hepatol. 2025; 15(2):102460.

PMID: 39760117 PMC: 11697564. DOI: 10.1016/j.jceh.2024.102460.


Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgery.

Heinrichs L, Fluegen G, Loosen S, Loberg C, Wittig L, Quaas A BJC Rep. 2024; 2(1):72.

PMID: 39323978 PMC: 11420066. DOI: 10.1038/s44276-024-00094-2.


Impact of imaging-diagnosed sarcopenia on outcomes in patients with biliary tract cancer after surgical resection: a systematic review and meta-analysis.

Ji J, Mi S, Hou Z, Zhang Z, Qiu G, Jin Z World J Surg Oncol. 2024; 22(1):229.

PMID: 39218917 PMC: 11367777. DOI: 10.1186/s12957-024-03516-0.


Prevalence and predictive value of sarcopenia in surgically treated cholangiocarcinoma: a comprehensive review and meta-analysis.

He J, Huang Y, Huang N, Jiang J Front Oncol. 2024; 14:1363843.

PMID: 38571501 PMC: 10989063. DOI: 10.3389/fonc.2024.1363843.


References
1.
Kuo S, Ahmad M, Dunn M, Montano-Loza A, Carey E, Lin S . Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation. Transplantation. 2019; 103(11):2312-2317. PMC: 6783339. DOI: 10.1097/TP.0000000000002741. View

2.
Santilli V, Bernetti A, Mangone M, Paoloni M . Clinical definition of sarcopenia. Clin Cases Miner Bone Metab. 2015; 11(3):177-80. PMC: 4269139. View

3.
Budczies J, Klauschen F, Sinn B, Gyorffy B, Schmitt W, Darb-Esfahani S . Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One. 2012; 7(12):e51862. PMC: 3522617. DOI: 10.1371/journal.pone.0051862. View

4.
Schefold J, Bierbrauer J, Weber-Carstens S . Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle. 2011; 1(2):147-157. PMC: 3060654. DOI: 10.1007/s13539-010-0010-6. View

5.
Waldner M, Foersch S, Neurath M . Interleukin-6--a key regulator of colorectal cancer development. Int J Biol Sci. 2012; 8(9):1248-53. PMC: 3491448. DOI: 10.7150/ijbs.4614. View